Noncompaction cardiomyopathy epidemiology and demographics

Jump to navigation Jump to search

Noncompaction Cardiomyopathy Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification & Nomenclature

Pathophysiology

Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Differentiating Noncompaction Cardiomyopathy from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Laboratory Studies

Genetic Testing

Electrocardiogram

Holter Monitoring

Chest X Ray

MRI

CT

Echocardiography

Biopsy

Treatment

Medical Therapy

Surgery

Noncompaction cardiomyopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noncompaction cardiomyopathy epidemiology and demographics

CDC on Noncompaction cardiomyopathy epidemiology and demographics

Noncompaction cardiomyopathy epidemiology and demographics in the news

Blogs on Noncompaction cardiomyopathy epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Noncompaction cardiomyopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

This is a rare genetic disorder. It is hard to know the true prevalance of disease as the diagnosis may be missed on echocardiography, and studies of prevalance focus on patients referred to teriary referral centers with congestive heart failure. The prevalence may increase as imaging modalities improve. In the largest study to date, the prevalence was 0.014%[1].

Prevalence in Children

The incidence is estimated to be 0.12 cases per 100,000 children [2].

Prevalence in Infants

Others have estimated the rate to be as high as 0.81 per 100,000 infants per calender year.

Male Predominance

There is an excess incidence of the disease in males (56% to 82%). This has been taken as evidence that in some cases there may be x-linked inheritance.

Age

In the initial description of the disease, the median age at diagnosis was 7 with a range from 11 months to 22 years[3]. Other studies have confirmed the presence of NCC in all age groups including the elderly.

References

  1. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000; 36: 493–500.
  2. Botto, LD. Left ventricular noncompaction. Orphanet encyclopedia. http://www.orpha.net/data/patho/GB/uk-LVNC.pdf
  3. Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation. 1990; 82: 507–513.

Template:WH Template:WS